Online Inquiry
Cat.#: ASSD-103
| Description | DAPI is a blue fluorescent DNA stain which is cell permeant at high concentrations. This is a ready made 1mg/mL staining solution. It is recommended to dilute this solution 1:1000 with your desired buffer for a 1µg/mL working concentration. 0.1µg/mL-10µg/mL is the typical working concentration used in most applications. DAPI also available. |
| Size | 1 mL, 5 mL, |
| Applications | The product is commonly used for cell imaging, cell counting, cell sorting (based on DNA content), apoptosis analysis, and HCA (high content analysis). |
| Chemical Name | 4',6-Diamidino-2-phenylindole dihydrochloride |
| Molecule Weight | 350.24 |
| Molecular formula | C16H15N5.2HCl |
| CAS Number | 28718-90-3 |
| Purity | >98% |
| Form | Pale yellow solution |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Important | When using this product for the first time, aliquot the DAPI ready-made solution and store at -20°C to avoid repeated freezing and thawing. Additionally, We strongly recommend storing this solution in the dark and away from light due to the compound's light sensitivity. |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-188 | Dansyl Chloride (AC188) | 1 g | inquiry |
| ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg | inquiry |
| ASSD-116 | Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) | 1 kit, 100 tests | inquiry |
| ASSD-110 | Picro Sirius Red Stain Kit (AC110) | 1 kit, 100 tests | inquiry |
| ASSD-158 | Eosin Y (AC158) | 1g | inquiry |
| ASSD-182 | 9-(2-Carboxy-2-cyanovinyl)julolidine (AC182) | 5 mg | inquiry |
| ASSD-223 | Antifade Fluorescence Mounting Medium (aqueous) (AC223) | 10 mL | inquiry |
| ASSD-153 | Brilliant Blue G (AC153) | 1g | inquiry |
| ASSD-154 | Brilliant Blue R-250 (AC154) | 1g, 5g | inquiry |
| ASSD-118 | BrdU (5-Bromo-2′-deoxyuridine) (AC118) | 200 mg, 100 mg, 1 g, 5g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.